-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: February 2012
Oncology Clinical Trials – Secrets of Success
At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that drugs in development for oncology indications had the lowest overall clinical trial success rate of all therapeutic areas in development since 2004. We have updated these numbers to include clinical trials through December 2011. Although overall success rates did improve slightly, oncology remained in last place. The chart below illustrates why oncology’s overall success rate is so low relative to Read More >
Presidential Memo Expands Purchases of Biobased Products and Creates Jobs
This week President Obama issued a Presidential Memorandum that challenges the federal government to substantially increase purchases of biobased products over the next two years, driving new job growth and innovation. The United States Department of Agriculture (USDA) already designates 64 categories of biobased products for federal procurement and this memorandum asks Agriculture Secretary Tom Vilsack to increase the number of both designated categories of and individual biobased products eligible for preferred purchasing by 50 Read More >
PTO Genetic Testing Study: What’s Patents Got to Do with It
The USPTO held a hearing on February 16 to collect testimony from interested parties to discuss factors affecting the availability of confirmatory, or second opinion, genetic testing. However, the hearing quickly devolved into testimonies addressing so called ‘gene patents’ and genetic testing more broadly. Dr. Hans Sauer testified on behalf of BIO and first raised the question whether there is in fact patient demand for an ‘independent second opinion genetic test.’ While doctors would likely Read More >
Dr. Jill Biden Kicks-Off Community College to Career Bus Tour
Dr. Jill Biden and U.S. Labor Secretary Hilda Solis will embark on a five-state “Community College to Career” bus tour to highlight innovative industry partnerships this week. The tour will begin on February 22 with a visit at Columbus State Community College before continuing to DG Medical. At DG Medical, Dr. Biden and Secretary Solis will join BioOhio and Sinclair Community College officials to see first-hand the impact of a U.S. Department of Labor grant-funded Read More >
Why Are Women Underrepresented in Scientific Fields?
Last week, I wrote about the systemic failure of public schools to prepare kids for science and math focused jobs. These aren’t just theoretical jobs of tomorrow, they are well-paid positions that American employers literally can’t fill fast enough. Despite this nation’s poor international ranking in both math and science educational achievement, tech focused jobs in the U.S. have grown at three times the normal pace through this past decade. This trend is expected to Read More >
